Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-04-12
2008-08-19
Ketter, James S (Department: 1636)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S04400A, C424S093200, C435S006120
Reexamination Certificate
active
07414020
ABSTRACT:
The invention provides for a novel human checkpoint kinase gene, hCDS1, comprising the nucleic acid sequence of residues 66-1694 of SEQ ID NO: 1, a protein expressed from the gene, fragments and functional equivalents of the protein. The invention also provides for pharmaceutical compositions comprising a hCDS1 protein, and methods utilizing the protein.
Blasina Alessandra
Luyten Walter H. M. L.
McGowan Clare
Parker Andrew E.
Ketter James S
Olson & Cepuritis, Ltd.
The Scripps Research Institute
LandOfFree
Human checkpoint kinase, hCDS1, compositions and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human checkpoint kinase, hCDS1, compositions and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human checkpoint kinase, hCDS1, compositions and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4013123